Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2010
This is the trial to see how our product is similar to remicade by comparing the results of blood samples when co-administered with methotrexate between 12.5 to 25 mg/week, oral or parenteral dose and folic acid in rheumatoid arthritis patients who are not receiving adequate response to methotrexate alone up to week 30.
Epistemonikos ID: b3e48b73fee4029773925f1cea821bfb82600489
First added on: Mar 23, 2022